Skip to main navigation

HOME
ABOUT ENZON
ROYALTY PRODUCTS
INVESTORS & MEDIA
Investor Relations
CONTACT US

Request Information
Email Alerts
Download Library
RSS News Feeds

Shareholder Tools

Downloads

Print

Downloads

Categories

Year

Aug 01, 2006

Enzon Reports Second Quarter 2006 Results; Company Continues to Build a Promising Oncology Franchise 28.4 KB

Aug 01, 2006

Enzon Pharmaceuticals Announces Advancements in Its Oncology Pipeline; Oncaspar Phase I solid tumor trial begins; IND approved for rhMBL study 13.6 KB

Jul 27, 2006

Enzon Pharmaceuticals and Santaris Pharma Enter into Global Collaboration to Develop Novel Cancer Therapeutics; Alliance Strengthens Both Companies' Oncology Pipelines 14.4 KB

Jul 25, 2006

Enzon to Release Earnings on Tuesday August 1, 2006; Conference Call and Webcast to Follow 7.3 KB

Jul 25, 2006

FDA Approves Enzon's Oncaspar(R) for First-Line Use in Acute Lymphoblastic Leukemia 12.2 KB

Jul 06, 2006

Enzon Pharmaceuticals Announces Completion Of Its Tender Offer For Its 4&frac12% Convertible Subordinated Notes Due 2008 8.1 KB

Jun 06, 2006

Enzon Pharmaceuticals Commences Tender Offer for Its 4 1/2% Convertible Subordinated Notes Due 2008 10.5 KB

Jun 01, 2006

Enzon Announces Exercise of Option to Purchase Additional Convertible Senior Notes 8.8 KB

May 18, 2006

Enzon Stockholders Approve Company Proposals at Annual Meeting 9 KB

May 18, 2006

Enzon Pharmaceuticals Prices Convertible Senior Notes 7.7 KB

Pagination

First page
Previous page
…
Page 11
Page 12
Page 13
Page 14
Page 15
Page 16
Page 17
Current page 18
Page 19
Next page
Last page

©2025 Enzon Pharmaceuticals, Inc., All Rights Reserved.